139934-80-8 Usage
General Description
The chemical "{4-[(2R,4S,5S)-5-[(tert-butoxycarbonyl)amino]-4-hydroxy-2-{[(1S)-2-hydroxy-2,3-dihydro-1H-inden-1-yl]carbamoyl}-6-phenylhexyl]phenoxy}acetic acid" is a complex compound with multiple functional groups. It contains a phenyl ring, an acetic acid moiety, and a dihydro-1H-inden-1-yl group. Additionally, it has a tert-butoxycarbonyl-protected amino group and a hydroxyl group. The compound has a long aliphatic chain with a hydroxy and amino group, and it is likely to have biological activity due to its complex structure. {4-[(2R,4S,5S)-5-[(tert-butoxycarbonyl)amino]-4-hydroxy-2-{[(1S)-2-hydroxy-2,3-dihydro-1H-inden-1-yl]carbamoyl}-6-phenylhexyl]phenoxy}acetic acid may have potential applications in medicinal chemistry and drug development due to its unique structure and multiple functional groups.
Check Digit Verification of cas no
The CAS Registry Mumber 139934-80-8 includes 9 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 6 digits, 1,3,9,9,3 and 4 respectively; the second part has 2 digits, 8 and 0 respectively.
Calculate Digit Verification of CAS Registry Number 139934-80:
(8*1)+(7*3)+(6*9)+(5*9)+(4*3)+(3*4)+(2*8)+(1*0)=168
168 % 10 = 8
So 139934-80-8 is a valid CAS Registry Number.
139934-80-8Relevant articles and documents
Synthesis and antiviral activity of a series of HIV-1 protease inhibitors with functionality tethered to the P1 or P1'phenyl substituents: X-ray crystal structure assisted design
Thompson,Fitzgerald,Holloway,Emini,Darke,McKeever,Schleif,Quintero,Zugay,Tucker,Schwering,Homnick,Nunberg,Springer,Huff
, p. 1685 - 1701 (2007/10/02)
By tethering of a polar hydrophilic group to the P1 or P1' substituent of a Phe-based hydroxyethylene isostere, the antiviral potency of a series of HIV protease inhibitors was improved. The optimum enhancement of anti-HIV activity was observed with the 4-morpholinylethoxy substituent. The substituent effect is consistent with a model derived from inhibitor docked in the crystal structure of the native enzyme. An X-ray crystal structure of the inhibited enzyme determined to 2.25 A verifies the modeling predictions.